Pancreatic Cancer Research

ResearcherUtrecht UniversityActive in the last 2 years

Leonard W. F. Seelen

Matched on ORCID iD 0000-0002-2712-8026; OpenAlex author ID A5074097739. Sources: OpenAlex.

Their work

Papers
16 (first author 5, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
79
Papers, trials and grants by year

2022: 1 paper · 2023: 2 papers · 2024: 5 papers · 2025: 3 papers · 2026: 5 papers

Papers 16

  1. Radiofrequency Ablation and Chemotherapy vs Chemotherapy Only in Locally Advanced Pancreatic Cancer: The PELICAN Randomized Clinical Trial. Co-author DOI 10.1001/jamanetworkopen.2026.3861↗
  2. Surgical outcomes from nationwide implementation of the international best practice for locally advanced pancreatic cancer (PREOPANC-4) study. First author DOI 10.1093/bjs/znag075↗
  3. Impact of preoperative radiotherapy on the risk of postpancreatectomy haemorrhage and major morbidity after resection of pancreatic adenocarcinoma including ar… Co-author DOI 10.1093/bjsopen/zrag058↗
  4. Tangential Versus Segmental Portomesenteric Venous Resection During Pancreatoduodenectomy for Pancreatic Cancer: An International Multicenter Cohort Study on S… Co-author DOI 10.1097/sla.0000000000006638↗
  5. The Value of Stereotactic Radiotherapy After FOLFIRINOX in Patients with Pancreatic Cancer with Vascular Contact-A Nationwide, Retrospective Cohort Study. First author DOI 10.3390/cancers18040700↗
  6. Evaluation of Short and Long-term Outcomes After Resection in Patients With Locally Advanced Versus (Borderline) Resectable Pancreatic Cancer. Co-author DOI 10.1097/sla.0000000000006289↗
  7. Nationwide implementation of the international multidisciplinary best-practice for locally advanced pancreatic cancer (PREOPANC-4): study protocol. First author DOI 10.1186/s12885-025-13554-w↗
  8. Quality of Life Among Patients With Locally Advanced Pancreatic Cancer: A Prospective Nationwide Multicenter Study. Co-author DOI 10.6004/jnccn.2024.7091↗
  9. 31P MR Spectroscopy in the Pancreas: Repeatability, Comparison With Liver, and Pilot Pancreatic Cancer Data. Co-author DOI 10.1002/jmri.29326↗
  10. Preoperative chemotherapy, radiotherapy and surgical decision-making in patients with borderline resectable and locally advanced pancreatic cancer. Co-author DOI 10.1038/s41575-023-00856-2↗
  11. Minimum and Optimal CA19-9 Response After Two Months Induction Chemotherapy in Patients With Locally Advanced Pancreatic Cancer: A Nationwide Multicenter Study. Co-author DOI 10.1097/sla.0000000000006021↗
  12. Nationwide Use and Outcome of Surgery for Locally Advanced Pancreatic Cancer Following Induction Chemotherapy. First author DOI 10.1245/s10434-023-14650-6↗
  13. ASO Author Reflections: Nationwide Experience on Locally Advanced Pancreatic Cancer Surgery After Induction Chemotherapy in the Netherlands: A Stepping Stone f… First author DOI 10.1245/s10434-023-14704-9↗
  14. Early Recurrence After Resection of Locally Advanced Pancreatic Cancer Following Induction Therapy: An International Multicenter Study. Co-author DOI 10.1097/sla.0000000000005666↗
  15. [Resection of locally advanced pancreatic cancer: careful selection and shared decision making]. Co-author PMID 37994726↗
  16. Added value of 3T MRI and the MRI-halo sign in assessing resectability of locally advanced pancreatic cancer following induction chemotherapy (IMAGE-MRI): pros… Last author DOI 10.1007/s00423-022-02653-y↗

Closest collaborators

The 25 strongest of 79 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Izaak Quintus Molenaar · 10 shared papers, 2023–2026 · strength 1.87
  2. Hjalmar C. van Santvoort · 10 shared papers, 2023–2026 · strength 1.87
  3. Marc G. Besselink · 9 shared papers, 2022–2026 · strength 1.57
  4. Bas Groot Koerkamp · 7 shared papers, 2023–2026 · strength 1.25
  5. Thomas F. Stoop · 7 shared papers, 2022–2026 · strength 1.23
  6. Johanna W. Wilmink · 6 shared papers, 2022–2026 · strength 1.07
  7. Casper H.J. van Eijck · 6 shared papers, 2023–2026 · strength 1.05
  8. Ignace H. J. T. de Hingh · 6 shared papers, 2022–2026 · strength 1.01
  9. Roeland F. de Wilde · 5 shared papers, 2023–2026 · strength 0.96
  10. Martijn W.J. Stommel · 5 shared papers, 2023–2026 · strength 0.89
  11. Vincent Erwin de Meijer · 4 shared papers, 2024–2026 · strength 0.76
  12. Christopher Lee Wolfgang · 4 shared papers, 2023–2026 · strength 0.70
  13. Sebastiaan Festen · 3 shared papers, 2024–2026 · strength 0.57
  14. Lois A. Daamen · 3 shared papers, 2023–2026 · strength 0.56
  15. Marco Del Chiaro · 3 shared papers, 2024–2026 · strength 0.56
  16. Nadia Haj Mohammad · 3 shared papers, 2024–2025 · strength 0.53
  17. Freek D. Daams · 3 shared papers, 2024–2026 · strength 0.52
  18. Marieke S. Walma · 3 shared papers, 2023–2025 · strength 0.49
  19. Gijs A. Patijn · 3 shared papers, 2023–2025 · strength 0.49
  20. Lilly J. H. Brada · 3 shared papers, 2023–2025 · strength 0.49
  21. Freek R. van ‘t Land · 2 shared papers, 2026 · strength 0.40
  22. Marjolein Y.V. Homs · 2 shared papers, 2025–2026 · strength 0.40
  23. Ingmar Florin Rompen · 2 shared papers, 2026 · strength 0.38
  24. Oskar Franklin · 2 shared papers, 2026 · strength 0.38
  25. Ernesto Sparrelid · 2 shared papers, 2026 · strength 0.38

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.